Q1 Earnings Estimate for Transcat Issued By HC Wainwright

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Investment analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for Transcat in a research report issued to clients and investors on Wednesday, May 21st. HC Wainwright analyst S. Buck anticipates that the scientific and technical instruments company will post earnings per share of $0.41 for the quarter. HC Wainwright has a "Buy" rating and a $116.00 price target on the stock. The consensus estimate for Transcat's current full-year earnings is $2.30 per share. HC Wainwright also issued estimates for Transcat's Q2 2026 earnings at $0.26 EPS, Q3 2026 earnings at $0.10 EPS and FY2026 earnings at $1.48 EPS.

Transcat (NASDAQ:TRNS - Get Free Report) last issued its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.66 by ($0.02). Transcat had a return on equity of 7.23% and a net margin of 6.22%. The firm had revenue of $77.13 million for the quarter, compared to analysts' expectations of $76.40 million. The company's quarterly revenue was up 8.8% on a year-over-year basis.

A number of other research firms have also issued reports on TRNS. Wall Street Zen upgraded Transcat from a "sell" rating to a "hold" rating in a research note on Wednesday. Oppenheimer downgraded shares of Transcat from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. Finally, Northland Securities reissued a "market perform" rating and set a $85.00 target price (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $114.00.

Transcat Trading Down 2.0%

TRNS traded down $1.83 during trading on Friday, hitting $90.21. 16,078 shares of the company's stock were exchanged, compared to its average volume of 81,879. The stock has a 50 day moving average price of $80.28 and a 200 day moving average price of $89.38. Transcat has a 1 year low of $67.56 and a 1 year high of $147.12. The company has a current ratio of 2.42, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14. The firm has a market cap of $839.75 million, a P/E ratio of 48.79 and a beta of 0.69.

Institutional Investors Weigh In On Transcat

Hedge funds have recently bought and sold shares of the business. Jones Financial Companies Lllp raised its position in shares of Transcat by 686.7% during the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock valued at $37,000 after acquiring an additional 309 shares in the last quarter. Quantbot Technologies LP bought a new position in Transcat in the 1st quarter valued at about $76,000. Aquatic Capital Management LLC increased its position in shares of Transcat by 1,052.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock valued at $122,000 after purchasing an additional 1,052 shares during the period. State of Wyoming bought a new stake in shares of Transcat in the 1st quarter worth approximately $95,000. Finally, Morgan Dempsey Capital Management LLC acquired a new position in shares of Transcat in the 4th quarter valued at $143,000. Institutional investors and hedge funds own 98.34% of the company's stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.